FILE - UK Prime Minister Boris Johnson speaks during a coronavirus press conference at 10 Downing Street on Jan. 22, 2021 in London, England. RELATED: Preliminary research finds some COVID-19 mutations may dampen vaccine effectivenessJohnson said that both the Oxford-AstraZeneca and Pfizer COVID-19 vaccines still remain effective against the U.K.
coronavirus variant.The U.K. plans to offer a first dose of vaccine to more than 15 million people by mid-February as it targets the country’s oldest and most vulnerable residents in the program's first phase.
Progressively younger groups of people will follow suit, with the government planning to reach everyone over 18 by September.The need is urgent.